Perhexiline and hypertrophic cardiomyopathy: a new horizon for metabolic modulation
- PMID: 20921436
- DOI: 10.1161/CIRCULATIONAHA.110.981464
Perhexiline and hypertrophic cardiomyopathy: a new horizon for metabolic modulation
Comment on
-
Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy.Circulation. 2010 Oct 19;122(16):1562-9. doi: 10.1161/CIRCULATIONAHA.109.934059. Epub 2010 Oct 4. Circulation. 2010. PMID: 20921440 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
